Sadick H, Riedel F, Oulmi J, Hörmann K, Bergler W F
Universitäts-Hals-Nasen-Ohren-Klinik Mannheim.
HNO. 2003 Feb;51(2):118-24. doi: 10.1007/s00106-002-0666-0.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant fibrovascular dysplasia with the main symptom of recurrent epistaxis. At present, only limited data are available on long-term results in the treatment of epistaxis. A part from the surgical treatment of the bleeding telangiectasia with argon plasma, an additional postoperative long-term treatment with estriol nose-ointment was performed and the results were analysed.
69 patients with HHT were treated with APC and estriol nose ointment. 43 patients could be examined over a follow-up period of more than 20 months. The bleeding frequency and intensity as well as the patient's satisfaction with the treatment result were evaluated and the serum estriol level determined.
After more than 20 months, the bleeding frequency and intensity were reduced in 95% of the patients compared to their preoperative findings. Under the influence of estriol, former berry-like telangiectasias became flatter and more even. Neither systemic side effects under topically applied estriol nor a relevant increase of serum estriol levels were observed.
The combined treatment regimen with APC and topically applied estriol provides a new treatment concept of epistaxis in HHT.
遗传性出血性毛细血管扩张症(HHT)是一种常染色体显性遗传性纤维血管发育异常疾病,主要症状为反复鼻出血。目前,关于鼻出血治疗的长期结果仅有有限的数据。除了用氩等离子体对出血性毛细血管扩张症进行手术治疗外,还进行了术后雌三醇滴鼻膏的长期治疗并分析结果。
69例HHT患者接受了氩等离子体凝固术(APC)和雌三醇滴鼻膏治疗。43例患者在超过20个月的随访期内接受了检查。评估了出血频率和强度以及患者对治疗结果的满意度,并测定了血清雌三醇水平。
20多个月后,与术前相比,95%的患者出血频率和强度降低。在雌三醇的作用下,先前的莓状毛细血管扩张变得更扁平、更均匀。局部应用雌三醇未观察到全身副作用,血清雌三醇水平也未出现相关升高。
APC与局部应用雌三醇的联合治疗方案为HHT鼻出血提供了一种新的治疗理念。